Securities and Exchange Commission (SEC) Amends Requirements to MD&A

The Securities and Exchange Commission (SEC) recently adopted new amendments as part of an ongoing effort to “modernize and enhance” regulations related to financial disclosures as well as management’s discussion and analysis (MD&A).

More

1stdibs.com, Inc. Announces Closing of Initial Public Offering

CFGI’s Capital Markets team supported 1stdibs.

More

Barkbox, Inc. and Northern Star Acquisition Corp. Close Merger

CFGI’s Capital Markets team assisted Barkbox, Inc.

More

5 Steps to Assess and Address the SEC’s Statement on SPAC Warrants

On April 12, 2021, the SEC issued a statement on the accounting for certain warrants issued by special purpose acquisition (SPAC) companies.

More

The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

A Guide to Bringing a UK Biotech Company to US Public Markets

With the United States’ thriving IPO market, low volatility and large pool of investors, many U.

More

Why the Up-C Structure Is a Good Alternative Route to an IPO

The umbrella partnership C corporation (Up-C) structure has been a popular option for pass-through entities looking to gain access to the capital markets.

More

Navigating SEC Comment Letters: Non-GAAP Disclosures and Metrics

Inevitably, companies looking to go public will face the prospect of comment letters from the Securities and Exchange Commission (SEC).

More

The Ultimate Guide to a Life Sciences IPO

The life sciences industry is in the middle of an IPO boom, with the 10 highest-valued biotech IPOs raising $3.

More